Internal Medicine, Infectious Disease · Brooklyn, NY
NPI
1831145648
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
475 Atlantic Ave Ste 2
Brooklyn, NY, 11217
Phone (718) 369-4850
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,316
158 services
Medicare patients, 2024
40
Average age 70
Drug cost, 2024
$5.8M
2,544 prescriptions
Company payments, 2025
$15K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan J Stein was code 36415 (venipuncture blood collection), 54 times for 25 patients. In total Alan J Stein billed 158 services in 11 codes, and Medicare paid $6,316.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 54 | 25 | $8.49 | $458 |
| 99213 Office E&M - Established | Office | 54 | 30 | $66.16 | $3,573 |
| 99442 Telephone Services | Office | 17 | 12 | $54.51 | $927 |
By year: 2022 $11K for 194 services; 2023 $8,478 for 172 services; 2024 $6,316 for 158 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 54 | 25 | $8.49 | $458 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan J Stein prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 474 prescriptions and refills. In total Alan J Stein wrote 2,544 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 474 | 504 | 54 | $1.9M |
| Rosuvastatin Calcium Generic | 214 | 264 | 31 | $1,218 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 199 | 235 | 25 | $894K |
| Atorvastatin Calcium Generic | 172 | 212 | 24 | $907 |
| Juluca Dolutegravir/Rilpivirine | 141 | 141 | 13 | $469K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 134 | 148 | 15 | $509K |
| Amlodipine Besylate Generic | 124 | 136 | 15 | $309 |
| Tivicay Dolutegravir Sodium | 115 | 115 | 12 | $253K |
| Descovy Emtricitabine/Tenofov Alafenam | 84 | 84 | 12 | $176K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 81 | 83 | Under 11 | $298K |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 65 | 65 | Under 11 | $300K |
| Dovato Dolutegravir Sodium/Lamivudine | 56 | 56 | Under 11 | $165K |
| Losartan Potassium Generic | 54 | 66 | Under 11 | $236 |
| Hydrochlorothiazide Generic | 49 | 57 | Under 11 | $78.98 |
| Fenofibrate Fenofibrate Nanocrystallized | 47 | 59 | Under 11 | $421 |
Brand drugs: 1,514 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan J Stein $15K ($15K in general payments such as food, travel and fees) from 3 companies. The largest payer was Gilead Sciences, Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.